Nurix Therapeutics, Inc. — Form D

Nurix Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2012-05-16. The offering totals $2K, of which $2K was reported sold. Industry: Other.

Offering

Issuer

Officers, directors & promoters (19)

NameRoleLocation
Kutzkey TimothyDirectorSan Francisco, CA
Kutzkey TimothyExecutive OfficerSan Francisco, CA
Leon ChenDirectorAustin, TX
Jeff TongDirectorSan Francisco, CA
Robert TjianDirectorSouth San Francisco, CA
David GoeddelDirectorAgoura Hills, CA
Julia GregoryDirectorSouth San Francisco, CA
Arthur SandsDirectorSan Francisco, CA
Arthur SandsExecutive OfficerSan Francisco, CA
Lori KunkelDirectorSan Francisco, CA
David LaceyDirectorSan Francisco, CA
Christine RingExecutive OfficerSan Francisco, CA
Hans van HouteExecutive OfficerSan Francisco, CA
Mark GoldsmithDirectorBurlingame, CA
Mark GoldsmithExecutive OfficerBurlingame, CA
Timothy KutzkeyDirectorSan Francisco, CA
Timothy KutzkeyExecutive OfficerSan Francisco, CA
Arthur T SandsDirectorThe Woodlands, TX
Arthur T SandsExecutive OfficerThe Woodlands, TX

Other filings by this issuer (5)

FiledFormOfferingSold
2020-03-26D$120.2M$120.2M
2015-09-18D$17.0M$17.0M
2014-01-02D$25.1M$2.1M
2013-03-28D/A$5.3M$5.3M
2012-05-15D$3.1M$3.1M

More